Di Wu

This inventor holds 57 USPTO granted patents and 17 published patent applications, plus 5 CIPO patents and 12 EPO patents, primarily in Medical Infusion Systems. Top assignees: Medtronic Minimed, Inc., Trace Genomics, Inc., Palantir Technologies Inc.. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Di Wu. Retrieved from https://idiyas.com/inventor/di-wu-b0le78zd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 57 (Patent Applications = 17)

% Patents Active = 94.7

CIPO Patents = 5 (Patent Applications = 10)

EPO Patents = 12 (Patent Applications = 15)

Average Co-Inventor Count = 5.7

ph-index = 5

Forward Citations = 140(Granted Patents)

Forward Citations (Not Self Cited) = 95(Dec 10, 2025)

Location History:

San Diego, CA (US) (2009 - 2017)
Montrose, CA (US) (2018 - 2023)
San Francisco, CA (US) (2022 - 2023)
Palo Alto, CA (US) (2017 - 2024)
Glendale, CA (US) (2020 - 2024)

Company Filing History:

46 out of 1,267

Medtronic Minimed, Inc.

Palantir Technologies Inc.

patents

4. 2 out of 501

Bp Corporation North America Inc.

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

Infusion Devices

Closed-Loop Systems

Insulin Delivery

Fluid Delivery

Hypoglycemia Management

Personalized Medicine

Gesture Recognition

Soil Health Indicators

Metagenomics

Carbohydrate Models

Correction Bolus

Sensor Feedback

57 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12685819 - Infusion devices and related meal bolus adjustment methods (2026-07-21),

2. 12573486 - Method and system for identifying fasting and postprandial periods based on detected events and using the same to train a mathematical model (2026-03-10),

3. 12488872 - Default carbohydrate consumption counts based on population carbohydrate consumption models (2025-12-02),

4. 12485224 - Safe correction boluses (2025-12-02),

5. 12478732 - Alert management based on sleeping status (2025-11-25),

6. 12370308 - Determination of adjustments to fluid delivery settings (2025-07-29),

7. 12362055 - Medical device configuration procedure guidance responsive to detected gestures (2025-07-15),

8. 12311146 - Personalized closed loop optimization systems and methods (2025-05-27),

9. 12311145 - Infusion devices and related rescue detection methods (2025-05-27),

10. 12268846 - Regulating delivery of insulin to a body of a user by a fluid delivery device (2025-04-08),

11. 12241882 - Soil health indicators using microbial composition (2025-03-04),

12. 12144966 - Determination of adjustments to fluid delivery settings (2024-11-19),

13. 12100498 - Configurable target values (2024-09-24),

14. 12073932 - Determination of adjustments to fluid delivery settings (2024-08-27),

15. 12064599 - Management of insufficient hypoglycemia response (2024-08-20),

Title: The Innovations of Di Wu: Pioneering Patents in Fluid Delivery Technology

Introduction

Di Wu, a notable inventor based in Glendale, California, has made significant contributions to the field of medical technology. With an impressive portfolio of 39 patents, he has been instrumental in developing innovative solutions that address critical healthcare challenges, particularly in fluid delivery systems.

Latest Patents

Wu's recent patents demonstrate his commitment to enhancing diabetes management through technology. One of his notable inventions is related to the "Determination of Adjustments to Fluid Delivery Settings." This patent outlines techniques for accessing meal size categories and historical meal events to optimize insulin delivery based on individual carbohydrate amounts. Another key patent involves "Configurable Target Values," where Wu developed methods to regulate glucose levels by determining a fluid delivery command, which aligns with the target glucose value prescribed by users. These advancements are essential for improving patient care in diabetes management.

Career Highlights

Throughout his career, Di Wu has worked with leading companies in the tech and healthcare sectors, including Medtronic Minimed, Inc. and Palantir Technologies Inc. His roles have allowed him to leverage his expertise in creating sophisticated medical devices that improve health outcomes for individuals managing chronic conditions.

Collaborations

Wu has collaborated with talented professionals in the industry, including coworkers Benyamin Grosman and Neha J. Parikh. Together, they have contributed to transformative projects that enhance the functionality and accessibility of medical devices, reflecting the synergy of their collective expertise.

Conclusion

Di Wu's innovations in the domain of fluid delivery technology underscore his role as a forward-thinking inventor. With 39 patents to his name, his work continues to shape the future of healthcare technology, making it more responsive and effective for patients everywhere.

Profile summary based on public USPTO records.